[AVDL] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[AVDL] Avadel Pharmaceuticals plc
Announcement Date
17-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -25.06%
YoY- 197.23%
Quarter Report
AVDL's Result
AVDL's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 14,229 14,229 19,826 39,675 32,087 47,320 7,028 12.46%
PBT -16,743 -6,630 -16,462 27,600 -18,846 -20,766 -10,075 8.82%
Tax -5,040 2,234 -691 5,921 3,451 8,919 -29 136.04%
NP -11,703 -8,864 -15,771 21,679 -22,297 -29,685 -10,046 2.57%
Tax Rate - - - -21.45% - - - -
Total Cost 25,932 23,093 35,597 17,996 54,384 77,005 17,074 7.20%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -82.25 -62.30 -79.55 54.64 -69.49 -62.73 -142.94 -8.79%
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.20 -0.24 -0.43 0.54 -0.54 -0.73 -0.26 -4.27%
EPS Diluted -0.20 -0.24 -0.43 0.52 -0.54 -0.73 -0.26 -4.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.